This collaborative article reviews chronic pulmonary aspergillosis (CPA) from the perspective of a multidisciplinary team comprising of respiratory physicians, radiologists, mycologists, dietitians, pharmacists, physiotherapists and palliative care specialists. The review synthesises current knowledge on CPA, emphasising the intricate interplay between clinical, radiological, and microbiological aspects. We highlight the importance of assessing each patient as a multidisciplinary team to ensure personalised treatment strategies and a holistic approach to patient care.
Share this post
Path:
Start » Living with Aspergillosis » General interest » Chronic pulmonary aspergillosis – a guide for the general physician
Latest News posts
Aspergillosis & Asthma: When Risks Peak Through the Year
November 10, 2025
🏗️ Damp, Dust and Indoor Air Quality
November 10, 2025
🫁 Understanding Chronic Cough in Aspergillosis
October 30, 2025
💼 Aspergillosis, Scent Sensitivity, and the Workplace
October 30, 2025
🩺 Article 1: Managing Side Effects of Aspergillosis Treatments
October 30, 2025
⚠️ Omeprazole and PPIs: What’s Behind the Recent Warning?
October 30, 2025
🩺 Article 1: Colonisation vs Infection in Airways Disease
October 30, 2025
Living with Primary Ciliary Dyskinesia (PCD) and Bronchiectasis
October 30, 2025
News archive
× Close
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
